Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
BACKGROUND:The objective of this study was to evaluate the performance of risk scores (Framingham, Assign and QRISK2) in predicting high cardiovascular disease (CVD) risk in individuals rather than populations. METHODS AND FINDINGS:This study included 1.8 million persons without CVD and prior statin...
Main Authors: | Tjeerd-Pieter van Staa, Martin Gulliford, Edmond S-W Ng, Ben Goldacre, Liam Smeeth |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4182667?pdf=render |
Similar Items
-
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
by: Marta Carrillo-Palau, et al.
Published: (2021-09-01) -
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
by: Shona Livingstone, MSc, et al.
Published: (2021-06-01) -
Randomised Evaluations of Accepted Choices in Treatment (REACT) trials: large-scale pragmatic trials within databases of routinely collected electronic healthcare records
by: van Staa Tjeerd-Pieter, et al.
Published: (2011-12-01) -
Cardiovascular risk stratification in new-onset diabetes by qrisk2 risk score and conventional risk score within 3 months of diagnosis of diabetes
by: Sujata Hiran, et al.
Published: (2018-01-01) -
Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.
by: Bart S Ferket, et al.
Published: (2014-01-01)